Preventive effect of FK143, a 5α-reductase inhibitor, on chemical hepatocarcinogenesis in rats

Clinical Cancer Research

Volumn 7, Issue 7, 2001, Pages 2096-2104

  Maruyama, Seiji ^a   Nagasue, Naofumi ^a   Dhar, Dipok Kumar ^a   Yamanoi, Akira ^a   El Assal, Osama N ^a   Satoh, Kimihiko ^a,b   Okita, Kiwamu ^c  

^a SHIMANE UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [3 [BIS(4 ISOBUTYLPHENYL)METHYLAMINO]BENZOYL] 1H INDOL 1 YL]BUTYRIC ACID; ANDROSTANOLONE; CYCLINE; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; N (2 FLUORENYL)ACETAMIDE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HORMONE BLOOD LEVEL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER NODULE; LIVER TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DIETHYLNITROSAMINE; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INDOLES; LIVER; MALE; PHENYLBUTYRATES; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344; RECEPTORS, ANDROGEN; TESTOSTERONE; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0034778038     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Trend in national public health
2. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
3. The long term efficacy of glycyrrhizin in chronic hepatitis C patients
4. Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice
5. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: A pilot study
6. Changing incidence of hepatocellular carcinoma in Japan
7. Spontaneous hepatomas in mice inbred from Ha:ICR Swiss stock: Effects of sex, cedar shavings in bedding, and immunization with fetal liver or hepatoma cells
8. Biochemical, pathological, and genetic aspects of spontaneous mouse hepatoma
9. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development
10. The effect of gonadectomy on the development of hepatomas induced by urethane
11. Influence of sex and sex hormones on development of hepatomas and other hepatic lesions in strain AxC rats ingesting 2-diacetylaminofluorene
12. Effects of neonatal and adult castration and of testosterone substitution in male rats on growth of enzyme-altered hepatic foci in the resistant hepatocyte model
13. Persistent sex differences in growth control of early rat liver lesions are programmed during promotion in the resistant hepatocyte model
14. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
15. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
16. Sex steroid receptor proteins in foetal, adult and malignant human liver tissue
17. Androgen receptors in hepatocellular carcinoma and surrounding parenchyma
18. Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels
19. Androgen and estrogen receptors in hepatocellular carcinoma and in the surrounding noncancerous liver tissue
20. Sex hormone receptors in hepatocellular carcinoma: Is there a rationale for hormonal treatment?
21. Androgen receptor in human liver: Characterization and quantitation in normal and diseased liver
22. The effect of several sex steroid hormones on the growth rate of three Morris hepatoma tumor lines
23. Effect of androgens and their manipulation on cell growth and androgen receptor (AR) levels in AR-positive and -negative human hepatocellular carcinomas
24. Inhibition of growth and induction of TGF-β1 in human hepatocellular carcinoma with androgen receptor by cyproterone acetate in male nude mice
25. Increased hepatic androgen receptor expression in female rats during diethylnitrosamine liver carcinogenesis: A possible correlation with liver tumor development
26. Sex-steroid receptors in the diethylnitrosamine model of hepatocarcinogenesis: Modifications by gonadal ablation and steroid replacement therapy
27. Recent studies on the mechanism of action of testosterone
28. Tissue distribution and kinetic characteristics of rat steroid 5α-reductase isozymes: Evidence for distinct physiological functions
29. FK143, a novel nonsteroidal inhibitor of steroid 5α-reductase. I. In vitro effects on human and animal prostatic enzymes
30. New principle for the analysis of chemical carcinogenesis
31. Purification, induction, and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis
32. Application of quantitative stereology to the evaluation of enzymealtered foci in rat liver
33. Fusion proteins containing androgen receptor sequences and their use in the production of poly- and monoclonal anti-androgen receptor antibodies
34. Radioimmunoassay of steroids
35. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice
36. Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α-dihydrotestosterone
37. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone
38. Inhibition of rat prostate carcinogenesis by a 5α-reductase inhibitor, FK143
39. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation
40. Characteristics of the biphasic action of androgens and of the potent anti-proliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells
41. Active cell death in hormone-dependent tissues
42. Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women
43. Androgen receptor in cirrhotic liver, adenomatous hyperplastic nodule and hepatocellular carcinoma in the human
44. Promotion of murine hepatocarcinogenesis by testosterone is androgen receptordependent but not cell autonomous. Proc. Natl. Acad. Sci
45. Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice
46. Strain dependent effects of sex hormones on hepatocarcinogenesis in mice